指南与共识产科

妊娠期高血压疾病国际临床实践指南系统评价

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines.
指南 / 共识 · Am J Obstet Gynecol · 2026-03-03

系统评价更新了2020年对妊娠期高血压疾病临床实践指南的分析,检索2015年1月至2025年1月发表的指南,最终纳入23部。采用AGREE II工具评估指南质量,其中半数被评为临床可用,半数需修改后可用。

要点

  • 慢性高血压合并非重度高血压的降压治疗推荐趋同,获9部指南认可。
  • 子痫前期预防用阿司匹林剂量推荐趋于一致,范围集中在75~162 mg/d。
  • 重度子痫前期的定义与早产性子痫前期终止妊娠时机仍存在不一致。

核心结论

  • 各指南间存在若干共识领域,但关键推荐仍存在差异,需建立可审计标准以促进有效实施。
  • 当差异反映证据不足或不确切时,需进一步研究以支持高质量指南制定,从而优化妊娠结局。

研究设计与样本

  • 对妊娠期高血压疾病国际及国家临床实践指南进行系统评价,检索Embase、MEDLINE与Cochrane Central Register of Controlled Trials。
  • 纳入2015年至2025年以英语、荷兰语、法语、德语、挪威语或西班牙语发表的指南,共23部,含15部更新版与8部新识别指南。
  • 采用AGREE II工具评估指南特征,由2名独立评价者提取数据,分歧经协商解决,仍存分歧由第3名评价者裁定。

主要发现

  • 使用AGREE II评分,半数指南被评为临床有用,另一半被评为修改后有用。
  • 自2020年以来,对慢性高血压女性非重度高血压推荐降压治疗的一致性增加,获9部指南认可。
  • 针对子痫前期风险增高或已患子痫前期女性的母胎监测指导有所改善,获9部指南认可,但风险增高人群的监测仍关注不足。
  • 阿司匹林预防子痫前期的剂量推荐虽仍有差异,但范围趋于一致,为75~162 mg/d。
  • 重度子痫前期的定义、早产性子痫前期的终止妊娠时机、阿司匹林具体剂量及启动时间仍存在持续不一致。

关键数值与推荐

  • 阿司匹林预防子痫前期的剂量推荐范围为75~162 mg/d。
  • 纳入指南的发表时间范围为2015年1月至2025年1月。
  • 23部指南中,15部为更新版,8部为新识别指南。

局限性

  • 重度子痫前期的定义在指南间持续不一致,影响临床应用的可比性。
  • 早产性子痫前期的终止妊娠时机推荐存在持续差异。
  • 阿司匹林具体剂量及启动时间仍有不一致,提示相关证据不充分或不确切。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review updates a 2020 analysis of clinical practice guidelines regarding hypertensive disorders of pregnancy, aiming to both support evidence-based practice and inform future research. DATA SOURCES: Searches were conducted in Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials. The search strategy used combinations of keywords and Medical Subject Headings terms relating to "pregnancy," "hypertension," "hypertensive disorders of pregnancy," and "guidelines," alongside Boolean operators to refine the search. Language and date filters were applied to restrict the results to documents published from January 2015 to January 2025 and in eligible languages. STUDY ELIGIBILITY CRITERIA: We included international and national clinical practice guidelines published between 2015 and 2025, in English, Dutch, French, German, Norwegian, or Spanish. STUDY APPRAISAL AND SYNTHESIS METHODS: A comprehensive search of bibliographic databases and gray literature identified 23 clinical practice guidelines, including 15 updates and 8 newly identified guidelines. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool was used to assess guideline characteristics. Data abstraction was by 2 independent reviewers, with disagreement resolved by consensus, with a third reviewer resolving outstanding difference of opinion. The results are presented descriptively. RESULTS: Half of clinical practice guidelines were scored as being 'clinically useful', while the other half were scored as useful with modifications, using the AGREE II score. Notable evolution since 2020 includes greater consistency in recommending antihypertensive treatment for nonsevere hypertension in women with chronic hypertension (endorsed by 9 clinical practice guidelines; advice remains more discordant for women with either gestational hypertension or preeclampsia) and improved guidance regarding maternal and fetal monitoring for women either at an increased risk of or with (endorsed by 9 clinical practice guidelines) preeclampsia, although the former remains underaddressed. Aspirin dosage (for preeclampsia prevention) recommendations, while still varied, now fall within a more consistent range of 75 to 162 mg/d. Persistent inconsistencies remain in the definition of 'severe' preeclampsia, timing of birth for preterm preeclampsia, and specific aspirin dosages and timing for commencement. CONCLUSION: While several areas of consensus exist between clinical practice guidelines, variability persists in key recommendations, and establishing auditable standards is essential for effective implementation. Where discrepancies reflect insufficient or inconclusive evidence, further research is paramount to support robust guideline development to optimize pregnancy outcomes.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Febles, Scott, Gillon, et al. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. Am J Obstet Gynecol. 2026. PMID: 41780627. doi:10.1016/j.ajog.2026.02.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。